SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is facing downward pressure amid community debate over recent earnings, where a revenue miss and concerns regarding the company's AI monetization strategy have overshadowed progress in its cloud infrastructure. While some traders view the stock as undervalued due to its significant cash holdings and potential spin-off catalysts, others remain skeptical, citing persistent weakness in advertising revenue and geopolitical risks associated with Chinese equities.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The community is debating the impact of escalating geopolitical tensions in the Middle East and the implementation of retaliatory U.S.-Canada tariffs, with many traders expressing concern that these factors will drive inflation and bond yields higher, potentially triggering a market correction. While some traders remain bullish, pointing to strong institutional momentum in AI-related sectors, others are warning that the current market environment is overextended and susceptible to volatility.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

Traders are primarily debating the long-term utility of the project's decentralized infrastructure, with many maintaining a bullish outlook based on developments like the integration of AI-native tools and enterprise use cases. Despite this conviction in the technology, sentiment remains dampened by the asset's significant price decline from historical highs and concerns regarding its tokenomics.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is trending as traders speculate on upcoming platform upgrades, including mainnet expansions and the anticipation of new liquidity-driven catalysts. While the community maintains a bullish outlook rooted in the protocol's dominance on the Base network, some voices urge patience, citing broader crypto market uncertainty and long-term consolidation.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors debate the impact of ongoing insider selling and the firm's path to commercial nuclear power, with bulls focusing on long-term AI data center demand and potential catalysts like regulatory updates, while bears point to the lack of revenue and the recent dilution.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trading lower as investors react to a disappointing robotaxi event that lacked clear timelines for mass production, compounded by a new NHTSA investigation into the vehicle's regulatory compliance. Traders are divided on the company's long-term autonomy strategy, with some viewing the Cybercab as a major breakthrough while others express concern over the lack of traditional controls and the slow pace of rollout.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased volatility and trader discussion centered on recent volume spikes, with persistent debate between investors who view it as a long-term play on financial infrastructure development and others who characterize the price action as a recurring pump-and-dump scheme. Sentiment remains highly polarized as traders weigh ongoing technical consolidation against skepticism over the project's transparency and historical price performance.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing volatility driven by anticipation ahead of upcoming earnings and a focus on long-term clinical catalysts, including upcoming data for its DM1 and FSHD programs. While some traders express frustration with the recent price decline and share dilution fears, others point to the stock's valuation relative to its revenue and pipeline potential as a setup for a potential rebound.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as traders react to a massive $131 billion indefinite-delivery/indefinite-quantity contract from the U.S. Air Force for the F-15 program, though the stock has struggled to maintain significant upward momentum due to ongoing concerns regarding delivery execution, potential union strike authorization, and general market skepticism. Community discussion remains divided, with many debating the impact of the new defense contract against persistent operational challenges and negative media sentiment.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

The semiconductor sector is experiencing significant volatility as traders debate the sustainability of AI-related hardware spending and potential broader market corrections. Market sentiment remains split, with some traders betting on further downside for chip stocks amid rising bond yields and geopolitical tensions, while others highlight the cyclical nature of these trades and the potential for an earnings-driven rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Axsome Therapeutics is trending following the recent FDA approval of Auvelity for the treatment of agitation associated with Alzheimer's dementia, with traders focusing on the stock's long-term growth potential and potential expansion into international markets. Investor sentiment remains bolstered by positive analyst coverage and management's increased peak sales guidance, though some community debate persists regarding the stock's valuation and the speed of commercial adoption.

Axsome Begins Phase III Study on AXS-05 for Smoking Cessation

AXSM begins dosing in the phase III SUMMIT study investigating AXS-05 for treating smoking cessation in adults.

Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsAmgen is a diversified pharmaceutical giant with high net margins. It reported nearly $8.1 billion in free cash flow for fiscal 2025...

Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run

Key PointsAxsome Therapeutics is performing well as it continues to expand its approved portfolio...

If You Invested $100 In Axsome Therapeutics Stock 10 Years Ago, You Would Have This Much Today

Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 10 years by 26.64% on an annualized basis producing an average annual return of 40.19%. Currently, Axsome Therapeutics has a marketread more...

Axsome's Q2 Earnings Meet Estimates, Auvelity Drives Y/Y Revenues

AXSM's Q2 earnings meet estimates, but revenues miss forecasts. Auvelity and other product sales drive year-over-year revenues.

AXSM Stock Advances On CEO’s Pipeline Claim: One New Drug Filing Yearly Through 2030  

Equity

The FDA has already accepted the company’s application seeking the greenlight for AXS-12.


Axsome (AXSM) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Axsome (AXSM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Axsome Therapeutics (AXSM) Reports Q2 Loss, Misses Revenue Estimates

Axsome (AXSM) delivered earnings and revenue surprises of 0.00% and -2.74%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Alpha Cognition Inc. (ACOG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates

Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of +56.52% and +98.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

• Reported GAAP EPS of -$0.99 down -2.06% YoY
• Reported revenue of $218.38M up 45.54% YoY
• Axsome Therapeutics believes that its current cash is sufficient to fund anticipated operations into cash flow positivity, based on the current operating plan, though no specific financial targets were provided.

Axsome Therapeutics experienced an increased net loss and significantly higher operating expenses during the second quarter of 2026, while the company faces ongoing regulatory uncertainty regarding its pipeline product AXS-12.

Axsome Therapeutics delivered robust year-over-year revenue growth driven by strong AUVELITY performance and successful commercial expansion, while the company continues to advance its innovative neuroscience pipeline toward key upcoming milestones.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$206.68
Prev Close	$208.35
Open	$207.01
Dividend Yield	0.00%
50-Day Moving Average	$223.76
Beta	0.73
Avg. Volume	669,521.86
PE Ratio	-54.98

52-Week High	$260.19
52-Week Low	$112.90
Market Capitalization	$10.83B
EPS (Annual)	-$3.68
Price to Book	129.76
Revenue Per Employee	$690,265.95

Feed

News

Sentiment

Earnings

Fundamentals

Info

AXSM Fundamentals